Patricia Fernandez-Nogueira

Patricia Fernandez-Nogueira

UNVERIFIED PROFILE

Are you Patricia Fernandez-Nogueira?   Register this Author

Register author
Patricia Fernandez-Nogueira

Patricia Fernandez-Nogueira

Publications by authors named "Patricia Fernandez-Nogueira"

Are you Patricia Fernandez-Nogueira?   Register this Author

10Publications

331Reads

44Profile Views

Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy.

J Clin Med 2020 Mar 12;9(3). Epub 2020 Mar 12.

Department of Biochemistry and Molecular Biomedicine, University of Barcelona; Institute of Biomedicine, University of Barcelona (IBUB), 08028 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9030776DOI Listing
March 2020

Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer.

Cancer Lett 2018 06 14;424:70-83. Epub 2018 Mar 14.

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2018.03.014DOI Listing
June 2018

The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase.

Clin Cancer Res 2016 05 15;22(10):2508-19. Epub 2015 Dec 15.

Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1808DOI Listing
May 2016

Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.

Cancer Res 2013 Nov 12;73(21):6424-34. Epub 2013 Sep 12.

Authors' Affiliations: Department of Medical Oncology and Pathology, Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer, Department of Medicine, University of Barcelona; Department of Cell Biology, Immunology, and Neurosciences, Medical School, University of Barcelona, Barcelona, Spain; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea; Department of Genetics, Oslo University Hospital Radiumhospitalet, Norway; and Department of Medicine and Experimental Oncology, Torino University, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-4573DOI Listing
November 2013

Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2.

J Cell Physiol 2012 Apr;227(4):1358-66

Department of Medical Oncology, Hospital Clínic, Medical School, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.22848DOI Listing
April 2012

Tumor promoting effects of CD95 signaling in chemoresistant cells.

Mol Cancer 2010 Jun 23;9:161. Epub 2010 Jun 23.

Medical Oncology, Institut d'Investigacions Biomèdiques Agustí Pi y Sunyer (IDIBAPS), Institut Clínic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic, Facultat de Medicina, Universitat de Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-9-161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906471PMC
June 2010